SCHEMBL8718534

SCHEMBL8718534

COC/C=C/c1ccc(C=O)cc1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.48
▸ CYP2A6 P11509 3/20 0.48
▸ ALDH1A3 P47895 2/20 0.41
▸ ALDH3A1 P30838 1/20 0.41
▸ IDO1 P14902 2/20 0.39
▸ TSHR P16473 1/20 0.39
▸ TYR P14679 1/20 0.39
▸ CYP2A13 Q16696 1/20 0.39
▸ PPARG P37231 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.38
▸ ALDH5A1 P51649 1/20 0.38
▸ ABAT P80404 1/20 0.38
▸ AKT1 P31749 1/20 0.38
▸ FDPS P14324 1/20 0.38
▸ LMNA P02545 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6610732 1.00 ALDH1A1 (0.48) ALDH1A1CYP2A6ALDH1A3ALDH3A1IDO1
SCHEMBL13679669 0.83 ALDH1A1 (0.41) ALDH1A1CYP2A6ALDH1A3ALDH3A1TSHR
SCHEMBL13679707 0.81 RELA (0.52) CYP2A6IDO1MAPTSMN1; SMN2
SCHEMBL6612670 0.80 ALDH1A1 (0.42) ALDH1A1CYP2A6ALDH1A3ALDH3A1IDO1
SCHEMBL6612673 0.80 ALDH1A1 (0.42) ALDH1A1CYP2A6ALDH1A3ALDH3A1IDO1
SCHEMBL17434657 0.79 TUBB4A (0.46) ALDH1A1IDO1LMNAMAPTHPGD
SCHEMBL6545108 0.79 KDM4E (0.57) ALDH1A1TSHRLMNAMAPTHPGD
SCHEMBL21835121 0.79 CYP19A1 (0.48) IDO1
SCHEMBL21835122 0.79 CYP19A1 (0.48) IDO1
SCHEMBL12016063 0.79 NFE2L2 (0.44) IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5840721-A INCREASE SENSITIVITY OF MULTIDRUG RESISTANT TUMOR CELLS TO ANTICANCER AGENTS ONTOGEN CORPORATION (US) 1998-11-24 — — US disclosed
Send feedback